DH
Income statement / Annual
Last year (2025), Definitive Healthcare Corp's total revenue was $241.52 M,
a decrease of 4.24% from the previous year.
In 2025, Definitive Healthcare Corp's net income was -$138.93 M.
See Definitive Healthcare Corp,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$241.52 M |
$252.20 M |
$251.42 M |
$222.65 M |
$166.15 M |
$118.32 M |
$85.50 M |
| Cost of Revenue |
$58.25 M
|
$54.73 M
|
$47.48 M
|
$42.63 M
|
$40.69 M
|
$30.47 M
|
$43.04 M
|
| Gross Profit |
$183.28 M
|
$197.47 M
|
$203.93 M
|
$180.03 M
|
$125.47 M
|
$87.85 M
|
$42.47 M
|
| Gross Profit Ratio |
0.76
|
0.78
|
0.81
|
0.81
|
0.76
|
0.74
|
0.5
|
| Research and Development Expenses |
$34.78 M
|
$36.52 M
|
$42.44 M
|
$34.89 M
|
$18.57 M
|
$11.06 M
|
$7.45 M
|
| General & Administrative Expenses |
$51.63 M
|
$49.27 M
|
$58.86 M
|
$51.56 M
|
$32.86 M
|
$14.37 M
|
$10.34 M
|
| Selling & Marketing Expenses |
$81.64 M
|
$83.81 M
|
$94.53 M
|
$89.59 M
|
$56.39 M
|
$34.33 M
|
$26.85 M
|
| Selling, General & Administrative Expenses |
$133.26 M
|
$133.07 M
|
$153.40 M
|
$141.15 M
|
$89.25 M
|
$48.70 M
|
$37.20 M
|
| Other Expenses |
$35.82 M
|
$738.70 M
|
$337.90 M
|
$48.04 M
|
$44.97 M
|
$43.97 M
|
$0.00
|
| Operating Expenses |
$203.86 M
|
$908.29 M
|
$533.73 M
|
$224.07 M
|
$152.78 M
|
$103.74 M
|
$44.64 M
|
| Cost And Expenses |
$262.10 M
|
$963.02 M
|
$581.22 M
|
$266.70 M
|
$193.47 M
|
$134.20 M
|
$87.68 M
|
| Interest Income |
$6.95 M
|
$14.59 M
|
$13.64 M
|
$2.79 M
|
$29.00 K
|
$0.00
|
$18.37 M
|
| Interest Expense |
$11.29 M
|
$14.84 M
|
$15.20 M
|
$11.20 M
|
$25.90 M
|
$36.49 M
|
$18.37 M
|
| Depreciation & Amortization |
$35.82 M
|
$51.67 M
|
$51.75 M
|
$56.90 M
|
$59.95 M
|
$59.58 M
|
$33.54 M
|
| EBITDA |
-$162.15 M |
-$567.24 M |
-$241.23 M |
$26.23 M |
$23.08 M |
$43.47 M |
$15.51 M |
| EBITDA Ratio |
-0.67
|
-2.25
|
-0.96
|
0.12
|
0.14
|
0.37
|
0.18
|
| Operating Income Ratio |
-0.09
|
-2.82
|
-1.31
|
-0.2
|
-0.16
|
-0.13
|
-0.03
|
| Total Other Income/Expenses Net |
-$188.67 M
|
$77.08 M
|
$21.62 M
|
$2.17 M
|
-$35.45 M
|
-$36.71 M
|
-$34.22 M
|
| Income Before Tax |
-$209.26 M
|
-$633.75 M
|
-$308.18 M
|
-$41.88 M
|
-$62.77 M
|
-$52.60 M
|
-$36.40 M
|
| Income Before Tax Ratio |
-0.87
|
-2.51
|
-1.23
|
-0.19
|
-0.38
|
-0.44
|
-0.43
|
| Income Tax Expense |
-$9.96 M
|
-$42.30 M
|
-$18.55 M
|
-$17.70 M
|
-$443.00 K
|
$0.00
|
$0.00
|
| Net Income |
-$138.93 M
|
-$413.12 M
|
-$202.39 M
|
-$7.22 M
|
-$51.91 M
|
-$52.60 M
|
-$36.40 M
|
| Net Income Ratio |
-0.58
|
-1.64
|
-0.8
|
-0.03
|
-0.31
|
-0.44
|
-0.43
|
| EPS |
-1.3 |
-3.54 |
-1.79 |
-0.0714 |
-0.19 |
-0.53 |
-0.24 |
| EPS Diluted |
-1.3 |
-3.54 |
-1.79 |
-0.0714 |
-0.19 |
-0.53 |
-0.24 |
| Weighted Average Shares Out |
$106.65 M
|
$116.64 M
|
$112.76 M
|
$101.11 M
|
$97.03 M
|
$97.03 M
|
$149.10 M
|
| Weighted Average Shares Out Diluted |
$106.65 M
|
$116.64 M
|
$112.76 M
|
$101.11 M
|
$97.03 M
|
$97.03 M
|
$149.10 M
|
| Link |
|
|
|
|
|
|
|
